PDF

Download The 2018 Agenda

Download The 2018 Agenda

Join Europe's Fastest Growing and Most Interactive TMF Forum To:

  • Hear first hand from the TMF Reference Model how the TMF Exchange Mechanism will help revolutionise the way we solve interoperability issues in eTMF platforms
  • Learn from Daiichi Sankyo how the TMF Management Tool will help manage your TMF at the study level to ensure you’re always on track for audits and inspections
  • Determine how to best prepare for TMF Inspections with an exclusive inspection readiness training day hosted by the HSRAA
  • Keep up with the digital revolution and achieve eTMF platform optimisation as Clintec and Biogen share their tips for a more proactive way of working with eTMFs
“I am so glad I did not miss this one! Highly relevant content, very helpful. Overall, a high standard of people ready to interact and discuss.” – GW Pharmaceuticals
Interoperability: The Top 5 Benefits and Burdens of Utilising the CRO eTMF

Interoperability: The Top 5 Benefits and Burdens of Utilising the CRO eTMF

Process and Quality, Quintiles and Pharma IQ take a closer look at how a modern day global contract research organisation (CMO) is approaching eTMF and assess the top 5 benefits and burdens of utilising the CMO’s electronic trial master files.

Trial Master File Inspection Readiness: CRO and Sponsor Perspectives

Trial Master File Inspection Readiness: CRO and Sponsor Perspectives

Pharma IQ gathered the perspectives of both the CRO and the sponsor in regards to the burning topic of inspection readiness when it comes to Trial Master Files.
Top Challenges with Late Stage Trial Master Files

Top Challenges with Late Stage Trial Master Files

The transition from a paper to an electronic Trial Master File (TMF) system is a significant task. In many cases, some pharma and biotech firms (sponsors) may find that they are in the late stages of digitising their TMF system resulting in some documents being left as hard copies. Ahead of the 2017 Trial Master File conference we examine the top challenges that are attached to operating trials with a late stage TMF.